A61K 39/00115
Apoptosis related proteins
Official title: {Apoptosis related proteins, e.g. survivin or livin}
A61K39/00115 (Apoptosis related proteins) appears on 136 US grants and 305 published applications in this corpus.
Search patents in A61K- Granted patents
- 136
- Published applications
- 305
- Assignees
- 167
- Inventors
- 540
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 4 |
| 2003 | 1 | 7 |
| 2004 | 1 | 11 |
| 2005 | 1 | 3 |
| 2006 | 0 | 6 |
| 2007 | 1 | 5 |
| 2008 | 1 | 4 |
| 2009 | 0 | 4 |
| 2010 | 1 | 8 |
| 2011 | 5 | 14 |
| 2012 | 3 | 9 |
| 2013 | 1 | 6 |
| 2014 | 5 | 15 |
| 2015 | 2 | 18 |
| 2016 | 8 | 20 |
| 2017 | 5 | 22 |
| 2018 | 8 | 14 |
| 2019 | 12 | 16 |
| 2020 | 10 | 22 |
| 2021 | 12 | 21 |
| 2022 | 7 | 23 |
| 2023 | 10 | 15 |
| 2024 | 13 | 19 |
| 2025 | 9 | 12 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Fusion peptide vaccines15 Sep 2026US 12,734,225 B2Treos Bio Limited
- Cancer vaccines targeting Survivin and uses thereof14 Jul 2026US 12,679,904 B2Inovio Pharmaceuticals, Inc.
- Neoantigen immunotherapies10 Mar 2026US 12,569,546 B2Iogenetics, LLC
- Polymeric nanovaccines and uses thereof3 Mar 2026US 12,564,643 B2Ramot at Tel-Aviv University Ltd.
- PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use28 Oct 2025US 12,454,565 B2Akston Biosciences Corporation
- Tumor cell vaccines20 Aug 2026US 2026/0240969 A1Neuvogen, Inc.
- Neoantigen immunotherapies20 Aug 2026US 2026/0240970 A1Iogenetics, LLC
- Polymeric nanovaccines and uses thereof21 May 2026US 2026/0137804 A1Ramot at Tel-Aviv University Ltd.
- Preparation method for adenovirus p53-loaded dendritic cell vaccine14 May 2026US 2026/0130977 A1Scinosen (Shenzhen) Gene Industry Development Co. Ltd.
- Allogeneic dendritic cell (allodc) tumor vaccine, and preparation method and use thereof16 Apr 2026US 2026/0102493 A1Shenzhen Frontiergate Biotechnology Co., Ltd
Most cited
By later US patents
- Compositions and methods for delivery of genetic material184US 5,739,118 AApollon Inc. · 1998
- Compositions and methods for delivery of genetic material132US 5,962,428 AApollon Inc. · 1999
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same90US 5,891,432 AThe Immune Response Corporation · 1999
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001